 |
|
 |
| |
TAKING INDUSTRY MATTERS TO TASK
THREE task teams have been put in place by the HPA to address matters critical to the efficient functioning of the industry: CAMS marketing requirements, responsible advertising and GMP guidelines.
 |
HPA executive director Mathabo Mashiane explained that the Marketing Code of Practice team would look at the marketing code requirements for CAMS as stipulated in the Medicines Control Act. Direct selling will come in for particular focus. She reminded members that the draft code was available on request. |
The team tackling the Advertising Standards Authority (ASA) code will be working on documents to be submitted to the ASA by 30 March. “We want to make sure that there is ethical behaviour in the industry in terms of responsible advertising, protecting the rights of the consumer and not misleading the public with unsubstantiated claims," Mashiane said.
"Our comments will emphasise the Appendices that affect the HPA - and anyone wanting to look at the Code can do so on the website: www.asasa.org.za. The Appendices of interest are A, D, E, F, H and M.”
The third task team has attended to comments from the HPA on draft amendments for GMP guidelines. “These have been completed and submitted, keeping in mind the challenges faced by CAMS manufacturers,” said Mashiane, “but interested parties are welcome to give further input and advice. We’re grateful for all the work and input that’s gone into these initiatives so far.”
|
|
 |
|
 |
| |
 |
 |
|
 |
| |
DRAFT REGULATIONS: Slow and steady...
THE word from the Department of Health is that comments submitted towards the end of last year on the CAMS draft regulations are being processed.
The HPA’s Dr Alan Tomlinson and Mathabo Mashiane, in discussion with the DoH, were informed that a select committee was working on the evaluations. Ten submissions were received from various organisations and associations plus some from individuals.
“This is an arduous task,” points out Tomlinson, “but we were told that there is pressure from above to complete it as soon as possible so as to move towards publishing the new regulations. However no dates have been set so we remain in anticipation.” |
|
 |
|
 |
| |
 |
 |
|
 |
| |
HISTORIC FIRST FOR AFRICAN MEDICINAL HERBS
AN African Herbal Pharmacopoeia that took nearly three years of research involving five African and European universities and 17 scientists is about to be launched.
This is the biggest achievement to date of the African Association of Medicinal Plant Standards (AAMPS) and marks a historic moment for those scientists involved in African medicinal plants.
| The AAMPS-African Herbal Pharmacopoeia will be the most up-to-date and extensive publication on the uses, quality, safety and efficacy of 52 of Africa’s most important medicinal plants. It promises to be indispensable for industry, science and research as a reference work of this nature is essential for the advance and global acceptance of African herbal medicines. |
 |
“The most important thing about this pharmacopoeia is that it will be a living database of African medicinal plants, as information will be updated continuously on the AAMPS website,” said Professor Kobus Eloff, chairman of AAMPS and head of the Phytomedicine Programme, University of Pretoria. "It will also be of great value in setting international standards for the therapeutic plants of the African continent."
Each of the monographs will provide comprehensive botanical, phytochemical and commercial information on the individual species. These were selected on the basis of a systematic review of published and unpublished literature. Extensive consultation across the continent ensured maximum diversity of input and data collection, with plant samples subjected to state of the art phytochemical analysis and fingerprinting. Each profile contains information and technical data relevant to collectors, practitioners, traders, producers and researchers.
AAMPS is a trade association that includes many of Africa’s leading scientists and organisations working in the field. All are dedicated to the development of quality control and standards for African medicinal plants and herbal products.
For more information write to...
|
|
 |
|
 |
| |
 |
| |
 |
| |
 |
| |

|
 |
|
 |
| |
COMPANY PROFILE
QUALITY SUPPLEMENTS FROM EUROPE
WHEN Roussina Veleva and Maya Nikolova decided to establish Nutrizest Natural Products, their objective was to import products of the highest quality.
 |
For these two Bulgarian women, supplements with a good track record in their native European market were the obvious option. In the course of their search for something unique, authentic and effective, two products attracted their attention: |
CitroPlus800, a grapefruit seed extract, and Urovit, a powder produced from the fruit of the American Cranberry. “We were aware that CitroPlus is prescribed by health practitioners in Bulgaria,” explained Veleva, “and discovered that it’s also had excellent feedback from European consumers.”
| With Veleva’s background in the import industry and Nikolova’s experience in food and chemical industry - coupled with a shared interest in health - this enterprising team has the necessary credentials to enter the health products industry. And they have achieved their primary objective. CitroPlus and Urovit are now available on the SA market. |
 |
Nutrizest Natural Products recently became the exclusive distributor for the German manufacturer GSE-Vertrieb GmbH in South Africa.
Nutrizest has ensured that the products abide by the strict regulation requirements of the EU and SA legislation. They are developed and manufactured in the European Union by GMP certified laboratories and manufacturers, are GM free and organically certified.
“The products are tested by Bionach, one of the most highly regarded and dependable testing laboratories in Germany,” Veleva told us. “Each batch is regularly tested for its content to make sure that it does not contain any residues, artificial preservatives or harmful substances.” Both products have NAPPI codes, which potentially enable consumers to claim on medical aid.
The team recently embarked on a drive to introduce their products to health shops and was very pleased by the response. The two supplements will initially be available from healthcare practitioners, and in health shops and selected beauty salons. For Veleva and Nikolova, this is just the beginning. They recently signed an agreement with Specialbalance Ltd in the UK to distribute their GMP quality nutritional supplements under the NutriZest banner.
BOUQUETS TO THE HPA…
TWO bouquets came the way of the HPA recently for the association’s relationship with the media. HPA Honorary President, Bruce Dennison, passed on compliments from two high-profile visitors who were guest speakers at HPA functions in Cape Town and Johannesburg last year.
Professor John Hathcock, VP of the Scientific & International Research Council for Responsible Nutrition in the USA, and Professor David Richardson, scientific advisor to the UK Council for Responsible Nutrition and IADSA, found the media reception very positive.
"They were amazed by the response," Dennison said. He went on to explain that, as a result of the HPA’s regular media meetings, a solid relationship had been built over the years.
“Journalists respect us and this state of affairs has impressed IADSA and industry associations in the USA as they have not managed to do the same with their own media. It’s great that they wish to learn from our example.”
|
|
 |
|
 |
| |

|
 |
|
 |
| |

FORTHCOMING EVENTS ...
TALKING ABOUT INFERTILITY
THE problem of infertility is increasingly being tackled with CAMS options and this will be the focus of a conference to be held at the Indaba Hotel in Johannesburg from 27 to 29 March.
| Initiated by Inge Dougans, head of the International Academy of Reflexology & Meridian Therapy, the conference is open to the public and therapists. There will be considerable discussion of the use of reflexology, and international and local experts will highlight ear, hand and foot reflexology as well as body reflexes and meridians in relation to infertility. |
 |
But speakers - from a gynaecologist and Chinese Medicine doctor to a nutritionist and homeopath - will speak on a range of approaches strategies.
Stands are available for related products to go on display.
To exhibit, contact Michelle Collett
WORKSHOPS FOR HPA MEMBERS
HPA members have indicated their interest in attending two workshops later this year to cover specific industry needs. One will cover Good Manufacturing Practice and the second will concentrate on Merchandising. Both are scheduled for the second half of the year in Cape Town and Johannesburg. Watch this space!
HEALTHY LIVING EXPO RIDES AGAIN!
THE Appletiser Healthy Living Expo 2009 has been booked again for Sandton City, so diarise 4 to 6 September. With Appletiser on board this year as Platinum Sponsor, this is a great opportunity to showcase products, supplements and equipment pertaining to a healthy lifestyle and healthy living.
 |
The 2008 expo was a huge success, with more than 11 500 people coming through the show over the weekend. |
The event is held in the Fountain Court with space for 30 exhibitors: get cracking and reserve your place now.
Contact Heather Hook
|
|
 |
|
 |
| |
 |
| |
 |
 |
|
 |
| |
 |
RESEARCH & REGULATION NEWS FROM AROUND THE WORLD (Supplied by IADSA) |
HOW CLINICALLY IS IT “PROVEN”?
AUSTRALIA: Concerned by the increasing use of the term "clinically proven" in health product adverts, the Australian Therapeutic Goods Authority has issued a warning notice...
Given the strength of this claim and the clear potential for it to mislead and deceive consumers, the Complaints Resolution Panel considers that its use in advertising should not even be contemplated unless unequivocally supported by robustly designed, published, peer-reviewed clinical trials which have been conducted upon the actual product being advertised or an identical formulation (as a minimum). Even where such evidence is available, the claim must also reflect the weight of all available evidence and not just the specific research being relied upon.
TIGHTENING UP ON COUGH MEDICINE
CANADA: Health Canada has released its decision on the use of cough and cold products, including natural health products, for children. A preliminary recommendation in 2007 stipulated that no OTC cough and cold product should be used in children under the age of two unless directed by a health-care practitioner. Following further analysis and input from a Scientific Advisory Panel, Health Canada has decided that certain over these OTC medicines should be labelled as not for use in children under six. Products for children from 6 to 12 will require enhanced labelling, child resistant packaging and dosing devices for liquid formulations.
FDA GUIDANCE ON CLAIMS & LABELING
US: Problems with claim substantiation and labeling are not limited to SA. The Food and Drug Administration (FDA) guidance on claims for dietary supplements is that manufacturers must possess adequate substantiation for each reasonable interpretation of a claim - and competent and reliable scientific evidence should be available. With regard to labelling, the guidance requires manufacturers to provide a prominent statement that their address or phone number is for reporting any serious adverse events associated with the product. The supplement industry maintains that the label changes sought by the FDA go beyond what the legislation requires, and would mean unnecessary and heavy costs.
ANYONE FOR A CUPPA NONI LEAF?
EU: Dried and roasted leaves of the Noni plant (Morinda citrifolia) have received authorization in the European Community as a novel food ingredient. The approval only extends to the use of the leaves in infusions with a set limit per cup.
LIST OF COLOURANT-FREE BRANDS
UK: The Food Standards Agency is encouraging food manufacturers to advise them of brands to be included on a list of foods free from certain colours: Sunset Yellow FCF (E110), Quinolene Yellow (E104), Carmiosine (E122), Allura Red (E129), Tartrazine (E102), Ponceau 4R (E124). The list will be published on the FSA website and, while not specifying individual products, will help consumers ascertain whether a product is likely to contain these colours.
SWEETENING WITH PURIFIED STEVIA
US: Two purified sweeteners made from the leaf of the stevia plant have been granted Generally Accepted as Safe status by the FDA for use as a general purpose sweetener in food, drink and supplements. The approval applies only to a highly purified form of stevia (95% or above) known as rebaudioside A.
BOTANICALS IN THE EU
EU: The first issue of the European Botanical Forum Fact File – a series of fact sheets on topics such as the history, usage, legal basis, benefits and claims for botanicals - was launched at the European Botanical Forum’s 4th Annual Workshop last December. Agenda items included health claims, quality and safety issues and the borderline between food and medicine products.
TOXICOLOGY IN THE 21st CENTURY
US: A recent report form the US National Academy, Toxicity Testing in the 21st Century: A Vision and a Strategy, is calling for faster development and use of tests on human cells – conducted in the laboratory or simulated on computer – as a way to predict health hazards. This would not only avoid animal testing but would facilitate further testing - particularly on combinations of compounds where safety information is currently incomplete. |
|
 |
|
 |
| |
 |
| |
 |

If you would like to share your company news with the industry please email:
fairallm@mweb.co.za or zansu@iafrica.com
Health Product Association of South Africa
PO Box 55544 • Northlands • Johannesburg 2116 •
South Africa
Tel : +27 11 789 4464 • Fax : +27 11 789 4464
email: hpasa@hpasa.co.za | website: www.hpasa.co.za
DISCLAIMER
The comments and opinions expressed in this newsletter are not necessarily the views or position of the Health Products Association.
|